Insmed
INSM
#677
Rank
C$48.81 B
Marketcap
C$226.44
Share price
-1.47%
Change (1 day)
129.85%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of December 2025 : C$0.81 Billion

According to Insmed's latest financial reports the company's total debt is C$0.81 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2025-12-31C$0.80 B-51.27%
2024-12-31C$1.64 B3.24%
2023-12-31C$1.59 B-0.09%
2022-12-31C$1.59 B104.83%
2021-12-31C$0.78 B51.16%
2020-12-31C$0.51 B-0.45%
2019-12-31C$0.51 B20.25%
2018-12-31C$0.43 B517.24%
2017-12-31C$69.86 M-5.12%
2016-12-31C$73.63 M111.13%
2015-12-31C$34.87 M20.9%
2014-12-31C$28.84 M37.65%
2013-12-31C$20.95 M8.69%
2012-12-31C$19.27 M6669.08%
2011-12-31C$0.28 M73.74%
2010-12-31C$0.16 M-25.1%
2009-12-31C$0.21 M-91.44%
2008-12-31C$2.55 M-24.07%
2007-12-31C$3.36 M-8.54%
2006-12-31C$3.68 M-50.89%
2005-12-31C$7.49 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$49.31 B 5,929.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$34.76 B 4,150.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$2.83 B 246.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$1.44 B 77.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.46 B-42.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$1.06 B 30.60%๐Ÿ‡บ๐Ÿ‡ธ USA